Inventor
Andrew Simon Cook
Inventor
Stow, MA, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes17%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
H04BTransmission2%
H04LTransmission of digital information, e.g. telegraphic communication2%
H04NPictorial communication, e.g. television2%
H04WWireless communication networks2%
PatentTitleYear
11,006,177System and method for utilizing a secured service provider memory202110,897,523System and method for implementing isolated service overlays between provider network service point and customer premises202110,428,062Geminal substituted aminobenzisoxazole compounds as agonists of a7-nicotinic acetylcholine receptors201910,370,370Aminobenzisoxazole compounds as agonists of a7-nicotinic acetylcholine receptors201910,183,938Geminal substituted quinuclidine amide compounds as agonists of a-7 nicotonic acetylcholine receptors201910,016,405Modulators of methyl modifying enzymes, compositions and uses thereof20189,980,952Modulators of methyl modifying enzymes, compositions and uses thereof20189,802,927'Oxadiazine compounds and methods of use thereof'20179,745,305'Modulators of methyl modifying enzymes, compositions and uses thereof'20179,371,331'Modulators of methyl modifying enzymes, compositions and uses thereof'20169,206,128'Modulators of methyl modifying enzymes, compositions and uses thereof'20159,085,583'Modulators of methyl modifying enzymes, compositions and uses thereof'20158,916,593'Alkoxy-substituted 2-aminopyridines as ALK inhibitors'20147,902,188'Morpholine dopamine agonists'20117,576,081'Morpholine dopamine agonists'20097,323,462'Morpholine dopamine agonists'20086,849,649'N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase'20056,660,756'N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2014Patents assigned to PFIZER (6)· patent assignee history
2003–2014Based in Sandwich, GB· patent location history
2015–2018Patents assigned to CONSTELLATION PHARMACEUTICALS INC (5)· patent assignee history
2015–2019Based in Stow, MA, US· patent location history
2019Patents assigned to AXOVANT SCIENCES GMBH (3)· patent assignee history
2019Patents assigned to FORUM PHARMACEUTICALS INC (2)· patent assignee history
2021Patents assigned to CENTURYLINK IP LLC (2)· patent assignee history
2021Based in Sheldon, IA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PFIZER | 6 | 2003–2014 |
| CONSTELLATION PHARMACEUTICALS INC | 5 | 2015–2018 |
| AXOVANT SCIENCES GMBH | 3 | 2019 |
| CENTURYLINK IP LLC | 2 | 2021 |
| FORUM PHARMACEUTICALS INC | 2 | 2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Stow, Massachusetts, US | 10 | 2015–2019 |
| Sandwich, GB | 6 | 2003–2014 |
| Sheldon, IA, US | 2 | 2021 |